Apex Frozen Foods Ltd

Apex Frozen Foods Ltd has announced the closure of its trading window for dealing in the company's equity shares. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the Un-Audited Financial Results for the second quarter ending September 30, 2026. The measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. It applies to all promoters, promoter group, directors, KMP, employees, designated persons, insiders, and their immediate relatives.

Apex Frozen Foods Ltd announced its participation in a two-day Non-Deal Roadshow in Mumbai on September 28-29, 2026. The company will engage with various investors and analysts during this event. The Investor Presentation (Q1FY27) from August 2026, which is publicly available, will be used. Apex Frozen Foods clarified that no Unpublished Price Sensitive Information (UPSI) will be shared. The company also noted that the schedule might be subject to changes due to unforeseen circumstances.

Apex Frozen Foods Ltd has announced September 10, 2026, as the record date to determine eligibility for the final dividend for the Financial Year 2025-26. The dividend, if declared at the upcoming 14th Annual General Meeting (AGM), will be 25%, equivalent to ₹2.50 per equity share. Shareholders are informed that the payment, subject to tax deductions, is scheduled for on or before October 16, 2026. This announcement aligns with SEBI Listing Regulations.

Apex Frozen Foods Ltd has announced its 14th Annual General Meeting (AGM) for FY 2025-26, scheduled for Thursday, September 17, 2026, at 10:00 AM. The meeting will be conducted entirely through video conferencing (VC) and other audio-visual means (OAVM), adhering to MCA and SEBI regulations. The company will present the Audited Financial Statements for FY 2025-26, along with the Board and Auditors' reports. Shareholders will also vote on the declaration of a final dividend of ₹2.50 per equity share (25%) and the re-appointment of Mr. Karuturi Satyanarayana Murthy as a director. The Annual Report, including the AGM notice, has been dispatched electronically to shareholders and uploaded to the company's website.

Apex Frozen Foods Ltd has submitted its Annual Report for FY 2025-26 and the Notice of its 14th Annual General Meeting (AGM). The AGM will be held on September 17, 2026, via video conferencing. The company reported strong financial performance for FY 2025-26, with Net Revenue of ₹9,311 million (14% Y-o-Y growth), EBITDA of ₹729 million (145% Y-o-Y growth), and Profit After Tax (PAT) of ₹388 million (902% Y-o-Y growth). The report highlights the company's resilience amidst global trade volatility, diversification into non-U.S. markets contributing significantly to revenue for the first time, and a strengthened balance sheet due to strong cash generation and debt reduction. The Annual Report is available on the company's website.

Apex Frozen Foods Ltd announced the outcome of its Board Meeting held on August 13, 2026. The board approved the Un-Audited Financial Results for the 1st Quarter ended June 30, 2026. The company also decided to convene its 14th Annual General Meeting on September 17, 2026, to be held through Video Conferencing. The financial results were reviewed by the Audit Committee and approved by the Board. The company operates in a single reportable segment, export of processed Shrimp, and does not have subsidiaries, making consolidated financial statements not applicable.

Apex Frozen Foods Ltd announced its Un-Audited Financial Results for the first quarter ended June 30, 2026. The Board of Directors approved these results, prepared under Ind AS, at a meeting held on August 13, 2026. The company also announced its 14th Annual General Meeting will be held on September 17, 2026, via Video Conferencing. The limited review report from statutory auditors, M/S. Padmanabhan Ramani & Ramanujam, was also submitted.

Apex Frozen Foods reported standalone net profit of ₹21.67 Cr for Q1 FY27 (quarter ended June 30, 2026), up 138% YoY (₹9.10 Cr) and 178% QoQ (₹7.79 Cr), with EPS of ₹6.93 against ₹2.91 a year ago. Revenue from operations was essentially flat YoY at ₹256.53 Cr (-0.6%) versus ₹258.16 Cr in Q1 FY26, though it jumped 52.9% QoQ off a seasonally weak Q4 FY26 base of ₹167.82 Cr. On the surface this reads as a sharp margin-expansion quarter: net profit margin rose to 8.45% from 3.52% YoY (4.64% QoQ), and EBITDA margin (PBT + finance cost + depreciation, over revenue) improved to roughly 12.9% from ~7.1% YoY — nominally above management's own target of sustaining ~7% EBITDA margin with 10% upside, flagged on the February 2026 concall. That headline needs a caveat. Roughly ₹18.83 Cr of the YoY increase in profit before tax traces to the 'changes in inventories of finished goods & biological assets' line, which credited ₹28.51 Cr to the P&L this quarter versus a ₹9.68 Cr credit a year ago — a larger build-up of unsold shrimp inventory flattered reported costs. That swing alone exceeds the entire ₹15.63 Cr YoY increase in PBT (₹28.59 Cr vs ₹12.95 Cr). Normalising for it (holding the inventory-change benefit at last year's level, same effective tax rate), PBT would have been about ₹9.76 Cr versus ₹12.95 Cr a year ago (down ~25%), and PAT roughly ₹7.40 Cr versus ₹9.10 Cr (down ~19%) — a decline rather than a jump. A lower effective tax rate (24.2% vs 29.8% YoY) also padded the reported PAT gain. No exceptional items were disclosed in any period, so this is a working-capital/inventory-valuation effect, not a one-off write-back — but it means headline profit growth overstates the underlying operating improvement, and whether it holds up depends on that inventory converting to sales in Q2 FY27. On guidance: management's February 2026 outlook called for revenue to grow to over ₹1,200 Cr within two years (aided by recovering US volumes post-tariff cuts and the India-EU FTA) while sustaining ~7% EBITDA margins with upside to 10%, and targeted 50% capacity utilisation by FY27. This quarter's flat YoY revenue (annualised run-rate ~₹1,026 Cr) shows no progress yet on the growth leg, even as the margin metric nominally screens ahead of target — though, as above, that figure is inventory-swing-assisted. No formal Street consensus for this specific quarter was found; broader analyst commentary points to a full-year FY27 PAT growth expectation of 15-20% (over FY26's ₹38.85 Cr) and management's own internal volume target of ~30% YoY, conditioned on stable trade/logistics — against which this quarter's flat value-terms revenue is not yet showing that growth. The company reiterated it has no subsidiaries, associates or JVs, so no consolidated statement was filed (Note 3). There were no other quarter-specific corporate developments (deals, capex, management changes) tied to these numbers; the FY26 final dividend of ₹2.50/share recommended on May 30, 2026 relates to the prior year, not this quarter.

Apex Frozen Foods Ltd has announced that its Board of Directors will convene on August 13, 2026, to consider and approve the Un-Audited Financial Results for the first quarter ended June 30, 2026. This meeting is in compliance with SEBI (LODR) Regulations, 2015. The trading window for dealing in the company's equity shares has been closed for promoters, directors, and designated employees from July 1, 2026, and will remain closed for 48 hours after the declaration of the financial results.

Apex Frozen Foods Ltd has announced the closure of its trading window for dealing in the company's equity shares. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the Un-Audited Financial Results for the first quarter ending June 30, 2026. The measure aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, restricting trading activities for promoters, directors, KMPs, employees, and their immediate relatives to prevent insider trading.